Ola Epemolu

1.8k total citations
29 papers, 912 citations indexed

About

Ola Epemolu is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Ola Epemolu has authored 29 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Organic Chemistry. Recurrent topics in Ola Epemolu's work include Genomics, phytochemicals, and oxidative stress (4 papers), Anesthesia and Sedative Agents (4 papers) and Analytical Chemistry and Chromatography (3 papers). Ola Epemolu is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), Anesthesia and Sedative Agents (4 papers) and Analytical Chemistry and Chromatography (3 papers). Ola Epemolu collaborates with scholars based in United Kingdom, United States and Malaysia. Ola Epemolu's co-authors include F. Hope, Kevin D. Read, A. Bom, Lucy C.J. Ellis, Alessio Ciulli, Julianty Frost, Pedro Soares, Sónia Rocha, Carles Galdeano and Morgan S. Gadd and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and Anesthesiology.

In The Last Decade

Ola Epemolu

29 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ola Epemolu United Kingdom 17 472 169 145 111 108 29 912
Carmine Lanni United States 15 246 0.5× 55 0.3× 44 0.3× 52 0.5× 9 0.1× 24 796
Elisabeth Ott Germany 13 215 0.5× 92 0.5× 173 1.2× 148 1.3× 9 0.1× 25 788
Snezana Mirkov United States 15 310 0.7× 15 0.1× 144 1.0× 46 0.4× 21 0.2× 24 801
Rupert Schreiner Germany 12 827 1.8× 28 0.2× 92 0.6× 161 1.5× 13 0.1× 17 1.3k
Naina Patel United Kingdom 18 482 1.0× 154 0.9× 178 1.2× 112 1.0× 77 0.7× 32 1.1k
Osamu Inagaki Japan 16 326 0.7× 15 0.1× 35 0.2× 88 0.8× 39 0.4× 74 834
Koen Raedschelders United States 14 358 0.8× 20 0.1× 28 0.2× 92 0.8× 6 0.1× 27 783
Jean‐Michel Scherrmann France 16 339 0.7× 34 0.2× 387 2.7× 59 0.5× 35 0.3× 27 968
Xiaojiao Li China 15 138 0.3× 38 0.2× 50 0.3× 55 0.5× 18 0.2× 65 696
Qiuping Ye China 17 285 0.6× 24 0.1× 151 1.0× 50 0.5× 11 0.1× 62 835

Countries citing papers authored by Ola Epemolu

Since Specialization
Citations

This map shows the geographic impact of Ola Epemolu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Epemolu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Epemolu more than expected).

Fields of papers citing papers by Ola Epemolu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ola Epemolu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Epemolu. The network helps show where Ola Epemolu may publish in the future.

Co-authorship network of co-authors of Ola Epemolu

This figure shows the co-authorship network connecting the top 25 collaborators of Ola Epemolu. A scholar is included among the top collaborators of Ola Epemolu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ola Epemolu. Ola Epemolu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mak, Kit‐Kay, Shiming Zhang, Madhu Katyayani Balijepalli, et al.. (2023). Synthesis of New Shogaol Analogues as NRF2 Activators and Evaluation of Their Anti-Inflammatory Activity, Modes of Action and Metabolic Stability. Antioxidants. 12(2). 475–475. 5 indexed citations
2.
Mak, Kit‐Kay, Shiming Zhang, Jestin Chellian, et al.. (2023). Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms. Antioxidants. 12(3). 595–595. 4 indexed citations
3.
Mak, Kit‐Kay, Shiming Zhang, Ola Epemolu, et al.. (2022). Synthesis and Anti‐Inflammatory Activity of 2‐Amino‐4,5,6,7‐tetrahydrobenzo[b]thiophene‐Derived NRF2 Activators. ChemistryOpen. 11(10). e202200181–e202200181. 9 indexed citations
4.
Mak, Kit‐Kay, Shiming Zhang, Madhu Katyayani Balijepalli, et al.. (2022). Anti-Inflammatory Effects of Auranamide and Patriscabratine—Mechanisms and In Silico Studies. Molecules. 27(15). 4992–4992. 3 indexed citations
5.
Mak, Kit‐Kay, Ola Epemolu, & Mallikarjuna Rao Pichika. (2021). The role of DMPK science in improving pharmaceutical research and development efficiency. Drug Discovery Today. 27(3). 705–729. 14 indexed citations
6.
Mak, Kit‐Kay, Shiming Zhang, Madhu Katyayani Balijepalli, et al.. (2020). Studies on the mechanism of anti-inflammatory action of swietenine, a tetranortriterpenoid isolated from Swietenia macrophylla seeds. Phytomedicine Plus. 1(1). 100018–100018. 19 indexed citations
7.
Foley, David, C.E. Naylor, G M Wood, et al.. (2019). Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1). ACS Medicinal Chemistry Letters. 10(3). 341–347. 7 indexed citations
8.
Foley, David, C.E. Naylor, Colin Robinson, et al.. (2018). Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1. Bioorganic & Medicinal Chemistry Letters. 28(19). 3255–3259. 19 indexed citations
9.
Smith, Paul W., Fabio Zuccotto, Robert H. Bates, et al.. (2018). Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future. ACS Infectious Diseases. 4(10). 1439–1447. 29 indexed citations
10.
11.
Frost, Julianty, Carles Galdeano, Pedro Soares, et al.. (2016). Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition. Nature Communications. 7(1). 13312–13312. 178 indexed citations
12.
Epemolu, Ola & A. Bom. (2014). The concept behind sugammadex. Revista Española de Anestesiología y Reanimación. 61(5). 272–276. 5 indexed citations
13.
Reid, Mark, Wilson Caulfield, Ola Epemolu, et al.. (2010). The discovery and SAR of indoline-3-carboxamides—A new series of 5-HT6 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(12). 3713–3716. 6 indexed citations
14.
Ray, Peter C., Jane Wright, Julia Adam, et al.. (2010). Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(4). 1084–1088. 18 indexed citations
15.
Bom, A., et al.. (2007). Selective relaxant binding agents for reversal of neuromuscular blockade. Current Opinion in Pharmacology. 7(3). 298–302. 31 indexed citations
16.
17.
18.
Porter, John B., Surinder Singh, K. P. Hoyes, et al.. (1994). Lessons from Preclinical and Clinical Studies with 1,2-Diethyl-3-Hydroxypyridin-4-One, CP94 and Related Compounds. Advances in experimental medicine and biology. 356. 361–370. 29 indexed citations
19.
Epemolu, Ola, Sukhjit Singh, Robert C. Hider, & L. A. Damani. (1992). The pharmacokinetics of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rats.. Drug Metabolism and Disposition. 20(5). 736–741. 3 indexed citations
20.
Barradas, M.A., D.P. Mikhailidis, Ola Epemolu, et al.. (1987). Comparison of the platelet pro‐aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222). British Journal of Haematology. 67(4). 451–457. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmine Lanni Breakdown of academic impact, for papers by Elisabeth Ott Breakdown of academic impact, for papers by Snezana Mirkov Breakdown of academic impact, for papers by Rupert Schreiner Breakdown of academic impact, for papers by Naina Patel Breakdown of academic impact, for papers by Osamu Inagaki Breakdown of academic impact, for papers by Koen Raedschelders Breakdown of academic impact, for papers by Jean‐Michel Scherrmann Breakdown of academic impact, for papers by Xiaojiao Li Breakdown of academic impact, for papers by Qiuping Ye
Rankless by CCL
2026